episode 157: biomarker testing improves outcomes for patients with non-small cell lung cancer
Published 4 months ago • 4 plays • Length 34:01Download video MP4
Download video MP3
Similar videos
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
3:15
how does biomarker testing impact non-small cell lung cancer care?
-
1:15
biomarker testing and lung cancer
-
49:54
practical principles of biomarker testing in advanced non-small cell lung cancer
-
5:53
targeted therapy in non-small cell lung cancer
-
17:43
how biomarker testing gave me better lung cancer treatment options | shyreece’s story (2 of 4)
-
19:35
my lung cancer symptoms: "they thought it was asthma!" (lauren’s story) | the patient story
-
1:17:22
biomarker-positive disease: approach to selecting targeted therapies in lung cancer and beyond.
-
0:55
challenges associated with biomarker testing for pd-l1 in nsclc
-
4:29
empowering providers to explain lung cancer biomarker testing to patients
-
1:01
improvements for uk biomarker testing
-
39:21
episode 169: how biomarker testing drives the use of targeted therapies
-
1:38
optimizing biomarker testing to steer treatment decisions
-
38:04
episode 180: learn how nurse practitioners use biomarker testing in cancer care
-
2:40
an expert explains predictive biomarker testing for lung cancer
-
4:37
emerging biomarkers in lung cancer
-
27:49
lung cancer: pre-analytical phase challenges and biomarker testing
-
1:39
when should a lung cancer patient be retested for biomarkers?
-
5:51
nsclc biomarker testing in the uk
-
0:57
struggles in full biomarker testing for lung cancer
-
1:08
dr. sholl on challenges with using tissue biopsy for biomarker testing in lung cancer
-
8:09
how does data inform lung cancer biomarker testing?